Trials / Completed
CompletedNCT04748536
Safety and PK of Repeated Doses of IRL201104 in Healthy Volunteers
A Randomised, Double-blind, Placebo-controlled, Parallel Group Study in Healthy Volunteers to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of IRL201104 to Support a Future COVID-19 Patient Study
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Revolo Biotherapeutics · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the safety, tolerability and pharmacokinetics of repeat doses of IRL201104 given to healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IRL201104 | lyophilised powder for reconstitution for IV dosing |
| DRUG | Placebo | Matching placebo for IRL201104 |
Timeline
- Start date
- 2021-01-29
- Primary completion
- 2021-04-05
- Completion
- 2021-04-05
- First posted
- 2021-02-10
- Last updated
- 2021-04-26
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04748536. Inclusion in this directory is not an endorsement.